Matrix, the pioneer in generative AI inference compute for data centers, has closed $275 million in Series C funding, valuing the company at $2 billion and bringing the total raised to date to $450 ...

Chip startup d-Matrix Inc. today disclosed that it has raised $275 million in funding to support its commercialization ...

California-based AI chip startup d-Matrix has gained a USD2 billion ($3.06 billion) valuation in its USD275 million Series C ...

Solo Ball had 23 points and Alex Karaban added 20 points and six rebounds as third-ranked UConn topped Columbia 89-62. Tarris ...

These questions come from my Udemy training and the certificationexams.pro website, resources that have helped many students pass the DP-100 certification. These are not DP-100 exam dumps or ...

Correspondence to Professor Shiv Kumar Sarin, Hepatology, Institute of Liver and Biliary Sciences, New Delhi, Delhi 110070, India; shivsarin{at}gmail.com Objectives Beta-blockers and endoscopic ...

WASHINGTON — Federal workers lined up around the corner outside of the Capital Area Food Bank in Southeast Washington, D.C., on Friday after missing their first full paycheck since the now 24-day ...

MILTON – Warrior Run used a powerful running attack, anchored by its offensive line, to methodically wrap up Milton, 31-10, on Friday to finish its regular season at 9-1. The Defenders downed the ...

Plans to relocate the Stone Fort Museum from the campus of Stephen F. Austin State University where it has been since 1936 have me filled with concern. At least it is on the table as part of a master ...

The finale will also screen in select theaters across the United States and Canada, allowing audiences to experience the final episode on the big screen. These details come alongside updates on the ...

Two British Columbia First Nations are taking the federal government to court to quash a decision approving the Ksi Lisims floating natural-gas facility and marine export terminal. The Lax Kw'alaams ...

RESEARCH TRIANGLE, N.C., Oct. 22, 2025 /PRNewswire/ -- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic ...